why choose us

First received: March 24, 2023

Clinical Trial: Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Wound Bleeding

Study Type: INTERVENTIONAL


Official Title: Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

Brief Summary: The goal of this clinical trial is to test if the study drug, BXP154 works to stop bleeding from a minor wound in patients that are on anticoagulant therapy.The main questions it aims to answer are:How long does it take to stop bleeding after BXP154 is applied to a wound?How many people require the use of a rescue treatment to stop bleeding?Does BXP154 reduce instances of re-bleeding after the bleeding has stopped initially?Is BXP154 safe and well-tolerated?

Read more